Synovial Chondromatosis

Synovial chondromatosis is a rare, non-cancerous joint condition that affects the lining of a joint, known as the synovium. The synovium normally produces synovial fluid, which lubricates the joint and allows smooth movement. In synovial chondromatosis, this lining begins to produce abnormal small nodules of cartilage.

Over time, these cartilage nodules can break free from the synovium and become loose bodies within the joint. These loose pieces may remain soft or gradually harden and calcify, turning into small bone-like fragments (known as ‘rice bodies’). As the number of loose bodies increases, they can interfere with normal joint movement, irritate joint surfaces, and cause pain, swelling, and stiffness.

How Does Synovial Chondromatosis Impact Your Hip Joint?

Synovial chondromatosis primarily affects the internal structures of a joint. The synovium thickens and becomes overactive, producing cartilage nodules instead of maintaining a smooth lining. As these nodules grow and detach, they occupy space within the joint capsule.

The presence of loose bodies can disrupt the normal mechanics of the joint in several ways:

Joint Surface Irritation: Loose cartilage or bone fragments rub against the cartilage covering the ends of bones, accelerating wear and tear. This can lead to accelerated arthritis.
Restricted Movement: Mechanical blockage may limit bending or straightening of the joint.
Inflammation: Repeated irritation can lead to chronic inflammation, causing swelling and pain.
Joint Instability or Locking: Larger loose bodies can temporarily jam the joint, leading to sudden locking or catching sensations.

Over time, these changes can damage the articular cartilage, the smooth surface that allows pain-free movement. This increases the risk of developing early osteoarthritis, particularly if the condition persists for years without treatment.

Risk Factors for Synovial Chondromatosis

Synovial chondromatosis is uncommon, but certain groups are at increased risk of developing the condition.

Adults Between 30 and 60 Years: The condition most often presents in middle adulthood.
Men: Males are affected more frequently than females.
Individuals with Pre-existing Joint Disease: Secondary synovial chondromatosis is more common in people with osteoarthritis, previous joint injury, or inflammatory joint conditions.

Children are rarely affected, and when symptoms appear at a younger age, careful assessment is required to rule out other conditions.

Causes of Synovial Chondromatosis

The exact cause of synovial chondromatosis remains incompletely understood, particularly in primary cases. However, several mechanisms are believed to be involved.

In primary synovial chondromatosis, synovial cells undergo abnormal transformation, producing cartilage in areas where it normally does not form. This process is considered a benign metaplastic change, meaning normal cells differentiate into another cell type. The mechanism underlying this is still unclear, but it is thought to involve altered cell signalling within the synovium.

In secondary synovial chondromatosis, the condition develops in response to ongoing joint irritation or damage.

Regardless of the underlying cause, the result is the same: the formation of cartilage nodules that interfere with joint function.

Symptoms of Synovial Chondromatosis

Common symptoms include:

Joint Pain: Often dull or aching, worsening with activity.
Swelling: Due to synovial thickening and fluid accumulation.
Stiffness: Particularly after periods of rest or inactivity.
Reduced Range of Motion: Difficulty fully bending or straightening the joint.
Locking or Catching: Sudden blockage caused by loose bodies moving within the joint.
Grinding or Clicking Sensations: Especially during movement.
Joint Instability: A feeling that the joint is not moving smoothly or reliably.

In advanced cases, pain may become constant, and joint function can be significantly limited. If secondary arthritis develops, symptoms may resemble those of osteoarthritis, including persistent stiffness and activity-related pain.

Preventing Synovial Chondromatosis

There is no guaranteed way to prevent primary synovial chondromatosis, as its underlying cause is not fully understood. However, certain strategies may help reduce the risk of secondary synovial chondromatosis and limit joint damage.

While prevention is limited, early detection and appropriate management are key to reducing long-term complications. Timely treatment can help preserve joint function, relieve symptoms, and minimise the risk of permanent joint damage.

Types of Synovial Chondromatosis

Primary Synovial Chondromatosis

This is the less common but more distinct form of the condition. It develops without any underlying joint disease. The synovial lining itself becomes abnormal and spontaneously produces cartilage nodules. These nodules may detach and form multiple loose bodies within the joint. Primary synovial chondromatosis often affects otherwise healthy joints and tends to be more aggressive, with a higher number of loose bodies and a greater risk of recurrence after treatment.

The knee is the most commonly affected joint, followed by the hip.

Secondary Synovial Chondromatosis

This form develops in response to an existing joint problem. Conditions such as osteoarthritis, previous trauma, inflammatory arthritis, or joint instability can irritate the synovium and trigger cartilage formation. The loose bodies in secondary synovial chondromatosis are usually fewer in number and are often larger fragments of cartilage or bone that have broken off from damaged joint surfaces rather than being newly formed by the synovium.

While both types cause similar symptoms, distinguishing between them helps to determine the likelihood of recurrence and the need for ongoing monitoring.

Diagnosis of Synovial Chondromatosis

Diagnosing synovial chondromatosis requires a combination of clinical assessment and imaging. Because symptoms can mimic other joint conditions, careful evaluation is essential.

Clinical Assessment: A detailed medical history is obtained, with emphasis on joint pain, swelling, stiffness, locking, and reduced range of motion. Dr Williams will examine the affected joint for tenderness, swelling, crepitus, and mechanical restriction. A history of joint disease or injury may suggest secondary synovial chondromatosis.
X-rays: Plain X-rays are often the first imaging test. They may show multiple calcified or ossified loose bodies within the joint, particularly in later stages. However, early disease may not be visible if the loose bodies are not yet calcified.
Magnetic Resonance Imaging (MRI): MRI is the most useful imaging modality for diagnosing synovial chondromatosis, particularly in the early or active stages. It can detect non-calcified cartilage nodules, synovial thickening, and joint effusion. MRI also helps assess cartilage damage and rule out other causes of joint symptoms.
CT Scan: CT scans provide detailed images of calcified loose bodies and are sometimes used for surgical planning, particularly in complex joints such as the hip or elbow.
Histological Examination: In some cases, tissue removed during surgery is examined under a microscope to confirm the diagnosis and exclude rare malignant conditions that can mimic synovial chondromatosis.

Treatment for Synovial Chondromatosis

While mild cases may be managed conservatively, many patients eventually require surgical treatment.

Observation and Monitoring: For patients with minimal symptoms and stable disease, careful monitoring may be appropriate. Regular follow-up and imaging are used to assess progression.
Pain Management: Pain-relieving medications, such as paracetamol or anti-inflammatory medications, may help control symptoms but do not address the underlying cause.
Activity Modification and Physiotherapy: Reducing activities that aggravate symptoms and engaging in guided physiotherapy can help maintain joint mobility and muscle strength. Physiotherapy is supportive rather than curative.
Surgical Removal of Loose Bodies: Surgery is the mainstay of treatment for symptomatic synovial chondromatosis. Loose bodies are removed to relieve mechanical symptoms and prevent further joint damage. This can often be done using minimally invasive arthroscopic surgery, depending on the joint involved.
Synovectomy: In cases of active disease, particularly primary synovial chondromatosis, partial or complete removal of the abnormal synovium may be performed to reduce the risk of recurrence.
Joint-Specific Surgery: In advanced cases with significant joint damage, additional procedures may be required, such as cartilage repair or, rarely, joint replacement if secondary arthritis is severe.

Surgical outcomes are generally good, with significant improvement in pain and function. However, recurrence is possible, especially in primary synovial chondromatosis, and long-term follow-up is often recommended.

What if Synovial Chondromatosis is Untreated?

If synovial chondromatosis is left untreated, the condition can progressively damage the affected joint and significantly impact quality of life.

Progressive Joint Damage: Ongoing irritation from loose bodies can wear down the articular cartilage, accelerating joint degeneration.
Development of Osteoarthritis: Chronic mechanical stress and inflammation increase the risk of early-onset osteoarthritis, even in younger patients.
Worsening Pain and Stiffness: Symptoms typically become more persistent and severe over time, limiting daily activities and work capacity.
Reduced Range of Motion: Mechanical blockage and joint surface damage can lead to permanent loss of movement.
Recurrent Joint Locking: Loose bodies may cause sudden locking episodes, increasing the risk of falls or further injury.

Although synovial chondromatosis is benign, it is not harmless. Early diagnosis and appropriate management are important for preserving joint function, relieving symptoms, and reducing the risk of long-term complications.

What is Synovial Chondromatosis?